This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
1 out of 159 
1 out of 100 Years Active: 2025
Title: Jiakang Sun: Innovator in Alzheimer's Disease Treatment
Introduction
Jiakang Sun is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for Alzheimer's disease. His innovative work has led to the creation of a patent that addresses critical health challenges associated with amyloid beta protein.
Latest Patents
Jiakang Sun holds a patent for "Anti-Aβ antibodies and antigen-binding fragments thereof." This patent includes murine, chimeric, or humanized anti-Abeta antibodies that possess a specific CDR region. The patent also covers an antigen-binding fragment, a pharmaceutical composition, and the usage of a humanized anti-Abeta antibody for preparing drugs aimed at treating diseases or disorders caused by amyloid beta protein, such as Alzheimer's disease. He has 1 patent to his name.
Career Highlights
Throughout his career, Jiakang Sun has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in medical research and drug development.
Collaborations
Jiakang Sun has collaborated with esteemed colleagues, including Hua Ying and Ling Zhang. These partnerships have fostered innovation and have been instrumental in the progress of his research endeavors.
Conclusion
Jiakang Sun's contributions to the field of Alzheimer's disease treatment through his innovative patents and collaborations highlight his role as a key inventor in the medical community. His work continues to pave the way for advancements in healthcare solutions.